Callahan Advisors’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.6M Buy
705,673
+1,778
+0.3% +$78.8K 2.38% 10
2025
Q4
$32.3M Sell
703,895
-10,339
-1% -$471K 2.65% 6
2025
Q3
$32.7M Sell
714,234
-7,263
-1% -$322K 2.77% 6
2025
Q2
$29.7M Buy
721,497
+11,665
+2% +$432K 2.67% 6
2025
Q1
$24.8M Sell
709,832
-706
-0.1% -$26.7K 2.36% 8
2024
Q4
$27.2M Sell
710,538
-1,968
-0.3% -$74.1K 2.56% 7
2024
Q3
$25.2M Sell
712,506
-300
-0% -$9.47K 2.46% 9
2024
Q2
$19.7M Sell
712,806
-3,158
-0.4% -$88K 2.05% 11
2024
Q1
$20M Buy
715,964
+8,475
+1% +$229K 2.1% 12
2023
Q4
$18.9M Buy
707,489
+9,774
+1% +$222K 2.2% 11
2023
Q3
$14.5M Buy
697,715
+18,650
+3% +$420K 1.83% 19
2023
Q2
$15.2M Buy
679,065
+106,417
+19% +$2.26M 1.85% 20
2023
Q1
$12.4M Buy
+572,648
New +$12.9M 1.61% 24
2022
Q4
Sell
-568,854
Closed -$12.5M 137
2022
Q3
$12.5M Sell
568,854
-10,802
-2% -$280K 1.8% 19
2022
Q2
$13.9M Buy
579,656
+24,546
+4% +$656K 1.85% 17
2022
Q1
$16.9M Buy
555,110
+51,893
+10% +$1.55M 1.93% 13
2021
Q4
$16.4M Buy
503,217
+7,522
+2% +$238K 1.84% 14
2021
Q3
$14.3M Buy
495,695
+17,215
+4% +$503K 1.8% 14
2021
Q2
$13.1M Buy
478,480
+13,249
+3% +$339K 1.67% 22
2021
Q1
$11.1M Sell
465,231
-6,850
-1% -$153K 1.5% 25
2020
Q4
$10.4M Sell
472,081
-112
-0% -$2.24K 1.53% 26
2020
Q3
$8.36M Sell
472,193
-14,937
-3% -$267K 1.37% 27
2020
Q2
$8.58M Sell
487,130
-204,730
-30% -$3.6M 1.52% 29
2020
Q1
$10.9M Sell
691,860
-39,485
-5% -$812K 2.29% 13
2019
Q4
$15.1M Buy
731,345
+8,089
+1% +$161K 2.42% 10
2019
Q3
$13.7M Buy
723,256
+7,203
+1% +$130K 2.39% 11
2019
Q2
$12.2M Sell
716,053
-2,122
-0.3% -$35.9K 2.19% 15
2019
Q1
$12M Buy
718,175
+15,566
+2% +$242K 2.23% 13
2018
Q4
$9.61M Buy
702,609
+2,918
+0.4% +$43.5K 2.05% 14
2018
Q3
$11.1M Sell
699,691
-2,105
-0.3% -$32K 2.06% 12
2018
Q2
$10.2M Buy
701,796
+13,697
+2% +$196K 2% 16
2018
Q1
$9.57M Buy
688,099
+6,424
+0.9% +$93K 1.96% 19
2017
Q4
$10.6M Sell
681,675
-8,686
-1% -$131K 2.1% 13
2017
Q3
$10.2M Buy
690,361
+4,636
+0.7% +$65K 2.14% 13
2017
Q2
$9.59M Sell
685,725
-645
-0.1% -$8.68K 2.09% 11
2017
Q1
$8.93M Buy
686,370
+15,704
+2% +$199K 2.01% 17
2016
Q4
$7.9M Buy
670,666
+12,736
+2% +$155K 1.9% 21
2016
Q3
$8.26M Buy
657,930
+33,518
+5% +$410K 2.07% 18
2016
Q2
$7.37M Sell
624,412
-2,140
-0.3% -$25.6K 1.94% 24
2016
Q1
$7.66M Buy
626,552
+47,349
+8% +$510K 2.1% 16
2015
Q4
$6.41M Buy
579,203
+22,929
+4% +$269K 1.83% 20
2015
Q3
$6.14M Buy
556,274
+21,966
+4% +$256K 1.89% 20
2015
Q2
$6.55M Buy
534,308
+17,071
+3% +$217K 1.89% 18
2015
Q1
$6.49M Buy
517,237
+16,103
+3% +$200K 1.89% 15
2014
Q4
$5.88M Buy
501,134
+2,785
+0.6% +$31.3K 1.73% 18
2014
Q3
$5.25M Buy
498,349
+12,114
+2% +$130K 1.63% 21
2014
Q2
$5.01M Buy
486,235
+9,602
+2% +$96.1K 1.59% 21
2014
Q1
$4.56M Buy
476,633
+5,600
+1% +$51K 1.55% 23
2013
Q4
$4.28M Buy
471,033
+21,626
+5% +$197K 1.49% 27
2013
Q3
$3.94M Buy
449,407
+30,997
+7% +$265K 1.5% 27
2013
Q2
$3.53M Buy
+418,410
New +$3.58M 1.44% 28

Other funds holding BN

Callahan Advisors's BN Position: Q1 2026 in Review

Callahan Advisors increased its Brookfield (BN) stake by 0.25% in Q1 2026, buying an estimated $78.8K and bringing the position to 705,673 shares worth $28.6M. The position accounts for 2.38% of the portfolio, ranked #10.

Callahan Advisors first reported a position in BN in Q2 2013 and has held it in 51 quarters since. The position peaked at $32.7M in Q3 2025. 914 funds tracked by Wall St. Rank hold BN as of Q1 2026.

  • Callahan Advisors held 705,673 shares of Brookfield worth $28.6M as of Q1 2026.
  • Callahan Advisors bought 1,778 Brookfield shares in Q1 2026, an estimated $78.8K.
  • Brookfield made up 2.38% of Callahan Advisors's portfolio in Q1 2026, its #10 holding.
  • Callahan Advisors first reported a position in Brookfield in Q2 2013 and has held it in 51 quarters since.
  • Callahan Advisors's Brookfield position peaked at $32.7M in Q3 2025.
  • 914 funds tracked by Wall St. Rank held Brookfield as of Q1 2026.

Based on Callahan Advisors's 13F filing for Q1 2026, filed 12 May 2026.